Publications
Publications
Show Results For
-
All HBS Web
(1,430)
- Faculty Publications (287)
COVID-19
→
Page 1 of
287
Results
→
- Article
Ein Booster für die Pharmabranche: Gerade erst hat die mRNATechnologie geholfen, Impfstoffe gegen Covid-19 zu entwickeln. Nun könnte sie wie Apples iOS die Grundlage für neue Innovationsplattformen bieten.
By: Ariel Dora Stern, Timo Minssen, W. Nicholson Price, II and Christoph Grimpe
- July 2022
- Article
Private Equity and COVID-19
By: Paul A. Gompers, Steven N. Kaplan and Vladimir Mukharlyamov
We survey more than 200 private equity (PE) managers from firms with $1.9 trillion of assets under management (AUM) about their portfolio performance, decisionmaking and activities during the Covid-19 pandemic. Given that PE managers have significant incentives to...
View Details
- May 2022
- Case
Byte
By: Boris Groysberg, Katherine Connolly Baden and Julia Kelley
In January 2021, Byte co-founders Scott Cohen and Blake Johnson reflected on how far their Los Angeles-based direct-to-consumer (DTC) orthodontics company had come since launching its clear aligners just a little over two years earlier. Cohen and Johnson were both...
View Details
- May 2022
- Case
RacingThePlanet’s 20-Year Marathon
By: Daniel Isenberg and William Kerr
Mary Gadams, founder and CEO of RacingThePlanet, has managed to stage sporting events in some of the world's most inhospitable locations for the last 20 years. New challenges, including the COVID-19 pandemic, have arisen. How can this small company navigate the global...
View Details
- May 2022
- Case
Deborah Quazzo at GSV Ventures
By: William A. Sahlman, Michael D. Smith and Nicole Tempest Keller
Facing a surge in investor interest in EdTech during the COVID-19 pandemic, GSV Ventures must decide whether to raise a larger Fund #2
View Details
- May 2022
- Case
Executive Decision-Making at Zola
By: Amy C. Edmondson and Michael Roberto
In April 2020, Rachel Jarrett, President and COO of wedding technology company Zola, called a meeting with the organization’s key decision-makers. The company had previously launched three business expansions: a vendor marketplace, a wedding apparel division, and a...
View Details
- 2022
- Working Paper
Causal Inference During A Pandemic: Evidence on the Effectiveness of Nebulized Ibuprofen as an Unproven Treatment for COVID-19 in Argentina
By: Sebastian Calonico, Rafael Di Tella and Juan Cruz Lopez Del Valle
Many medical decisions during the pandemic were made without the support of causal evidence obtained in clinical trials. We study the case of nebulized ibuprofen (NaIHS), a drug that was extensively used on COVID-19 patients in Argentina amidst wild claims about its...
View Details
- Article
Early Withdrawal of Pandemic Unemployment Insurance: Effects on Earnings, Employment and Consumption
By: Kyle Coombs, Arindrajit Dube, Calvin Jahnke, Raymond Kluender, Suresh Naidu and Michael Stepner
In June 2021, 22 states ended all supplemental pandemic unemployment insurance (UI) benefits, eliminating benefits entirely for over 2 million workers and reducing benefits by $300 per week for over 1 million workers. Using anonymous bank transaction data and a...
View Details
- May 2022
- Article
Policy Stringency and Mental Health During the COVID-19 Pandemic: A Longitudinal Analysis of Data from 15 Countries
By: Lara B. Aknin, Bernardo Andretti, Rafael Goldszmidt, John F. Helliwell, Anna Petherick, Jan-Emmanuel De Neve, Elizabeth W. Dunn, Daisy Fancourt, Elkhonon Goldberg, Sarah P. Jones, Ozge Karadag, Elie Karam, Richard Layard, Shekhar Saxena, Emily Thornton, Ashley Whillans and Jamil Zaki
To date, public health policies implemented during the COVID-19 pandemic have been evaluated on the basis of their ability to reduce transmission and minimise economic harm. We aimed to assess the association between COVID-19 policy restrictions and mental health...
View Details
- April 18, 2022
- Article
Will mRNA Technology Companies Spawn Innovation Ecosystems?
By: Christoph Grimpe, Timo Minssen, W. Nicholson Price, II and Ariel Dora Stern
The mRNA technologies that helped rapidly create effective COVID-19 vaccines could become technology platform businesses, which has tremendous implications for players in the world of drug development. These platforms could attract other companies interested in...
View Details
- April 2022
- Teaching Note
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a...
View Details
Keywords:
Health;
COVID-19 Pandemic;
Primary Care;
Leadership;
Change Management;
Women Executives;
Retail;
Pharmacy;
Pharmacy Benefit Manager;
Clinical Trials;
Vaccination;
Acquisition;
Innovation and Invention;
Transformation;
Retail Industry;
Pharmaceutical Industry;
Health Industry;
United States
- April 2022
- Case
Connecting Students in Chattanooga (A)
By: Jan W. Rivkin and Manjari Raman
As COVID-19 hit and school buildings closed across America in the spring of 2020, tens of thousands of K-12 students in Chattanooga’s Hamilton County lacked the high-quality Internet service required to connect them to remote education. Bryan Johnson, superintendent...
View Details
- April 2022
- Supplement
Connecting Students in Chattanooga (B)
By: Jan W. Rivkin and Manjari Raman
- Article
Creating High-Impact Coalitions: CEOs Can Lead the Charge on Society’s Biggest Problems
By: Rosabeth M. Kanter and Tuna Cem Hayirli
Traditionally, responses to crises and societal problems—the COVID-19 pandemic, natural disasters, racial inequities—are considered the responsibility of the public sector and NGOs. But addressing the world’s most critical problems requires leadership, resources, and...
View Details
- March 2022 (Revised June 2022)
- Case
DaVita Responds to COVID
By: Susanna Gallani and David Lane
Early in August 2021, DaVita CEO Javier Rodriguez was assessing the ongoing impact of the COVID-19 pandemic on his firm, which provided life-sustaining kidney dialysis to roughly 240,000 people. Effective infection control practices and information sharing had ensured...
View Details
Keywords:
COVID-19 Pandemic;
Change Management;
Communication;
Talent and Talent Management;
Fairness;
Values and Beliefs;
Corporate Accountability;
Health Care and Treatment;
Health Pandemics;
Human Resources;
Employee Relationship Management;
Retention;
Wages;
Working Conditions;
Leadership Style;
Crisis Management;
Organizational Culture;
Health Industry;
United States
- 2022
- Article
The Great Resignation Didn't Start with the Pandemic
By: Joseph B. Fuller and William R. Kerr
COVID-19 spurred on the Great Resignation of 2021, during which record numbers of employees voluntarily quit their jobs. But what we are living through is not just short-term turbulence provoked by the pandemic. Instead, it’s the continuation of a trend of rising quit...
View Details
- March 2022
- Case
The Goldman Sachs 10,000 Small Businesses Program: 2009-2021
By: Leonard A. Schlesinger and Julia Kelley
In December 2021, more than a decade after its founding, Goldman Sachs’s 10,000 Small Businesses program was still going strong — and the firm now needed to evaluate potential program modifications to reach a wider group of small business owners. Launched in the...
View Details
Keywords:
COVID-19 Pandemic;
Small Business;
Business Education;
Curriculum and Courses;
Government and Politics;
Knowledge;
Knowledge Dissemination;
Labor;
Employment;
Human Capital;
Management;
Goals and Objectives;
Organizations;
Mission and Purpose;
Corporate Social Responsibility and Impact;
Programs;
Networks;
Social Enterprise;
Society;
Strategy;
Demographics;
Diversity;
Financial Services Industry;
North and Central America;
United States;
New York (city, NY);
New York (state, US)
- March 2022 (Revised June 2022)
- Case
Transforming Kimball International, Inc. (A)
By: Lynn S. Paine and Will Hurwitz
Kimball International, Inc. (KII), led by CEO Kristie Juster, and its board of directors, chaired by Kim Ryan, faced critical questions about KII’s future in the spring of 2021. Two years earlier, the board had appointed Juster as the new CEO of KII, a publicly traded,...
View Details
Keywords:
Board Of Directors;
Board Committees;
Board Decisions;
Board Dynamics;
CEO Compensation;
CEO Succession;
Compensation Committee;
Compensation Consultants;
Compensation Design;
Compensation Mix;
Corporate Purpose;
COVID-19;
ESG;
Furniture;
Furniture Industry;
Manufacturing;
Midwest;
Pandemic;
Purpose;
Spin Off;
Strategic Change;
Strategic Decisions;
Strategic Evolution;
Target-setting;
Executive Compensation;
Family Ownership;
Governance;
Restructuring;
Strategy;
Transformation;
Manufacturing Industry;
United States
- March 2022
- Supplement
Transforming Kimball International, Inc. (B)
By: Lynn S. Paine and Will Hurwitz
Supplements the (A) case.
View Details
Keywords:
Board Of Directors;
Board Committees;
Board Decisions;
Board Dynamics;
CEO Compensation;
CEO Succession;
Compensation Committee;
Compensation Consultants;
Compensation Design;
Compensation Mix;
Corporate Purpose;
COVID-19;
ESG;
Furniture;
Furniture Industry;
Manufacturing;
Midwest;
Pandemic;
Purpose;
Spin-off;
Strategic Change;
Strategic Decisions;
Strategic Evolution;
Target-setting;
Executive Compensation;
Family Ownership;
Governance;
Restructuring;
Strategy;
Transformation;
Manufacturing Industry;
United States
- 2022
- Working Paper
Stock Market Stimulus
By: Robin Greenwood, Toomas Laarits and Jeffrey Wurgler
The stock market crash in March 2020 was followed by a historic rebound, particularly among stocks favored by retail investors. We study the effects of the arrival of the three rounds of “stimulus checks” to U.S. taxpayers and the single round of direct payments to...
View Details
Keywords:
Stock Market;
COVID-19 Pandemic;
Fiscal Stimulus;
Stimulus Payments;
Impact;
Stocks;
System Shocks;
Price;
Spending;
United States;
Hong Kong;
China